Landscape Capital Management L.L.C. cut its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 83.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,740 shares of the real estate investment trust's stock after selling 65,508 shares during the quarter. Landscape Capital Management L.L.C.'s holdings in Sabra Healthcare REIT were worth $223,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. State of Michigan Retirement System lifted its position in Sabra Healthcare REIT by 1.1% during the 1st quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock worth $990,000 after buying an additional 600 shares in the last quarter. Louisiana State Employees Retirement System lifted its position in Sabra Healthcare REIT by 0.9% during the 1st quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock worth $1,158,000 after buying an additional 600 shares in the last quarter. Harbor Capital Advisors Inc. lifted its position in Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after buying an additional 642 shares in the last quarter. Diversify Advisory Services LLC lifted its position in Sabra Healthcare REIT by 5.7% during the 1st quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock worth $226,000 after buying an additional 689 shares in the last quarter. Finally, IFP Advisors Inc lifted its position in Sabra Healthcare REIT by 16.2% during the 1st quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock worth $88,000 after buying an additional 706 shares in the last quarter. 99.40% of the stock is owned by institutional investors.
Sabra Healthcare REIT Trading Down 1.0%
Shares of SBRA stock opened at $19.11 on Tuesday. The firm has a 50 day moving average price of $18.57 and a two-hundred day moving average price of $17.82. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.58 billion, a PE ratio of 25.15, a price-to-earnings-growth ratio of 1.52 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, beating the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter in the prior year, the business earned $0.36 earnings per share. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.
Sabra Healthcare REIT Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. JMP Securities upped their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. BMO Capital Markets upped their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday, August 25th. Scotiabank upped their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a report on Monday, June 23rd. Finally, Wells Fargo & Company upped their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of "Moderate Buy" and an average price target of $20.43.
Get Our Latest Analysis on Sabra Healthcare REIT
About Sabra Healthcare REIT
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.